EAM
EIDX
Eventide Asset Management’s Eidos Therapeutics, Inc. Common Stock EIDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-317,417
| Closed | -$41.8M | – | 179 |
|
|
2020
Q4 | $41.8M | Hold |
317,417
| – | – | 0.64% | 57 |
|
|
2020
Q3 | $16M | Buy |
317,417
+104,417
| +49% | +$5.28M | 0.31% | 89 |
|
|
2020
Q2 | $10.2M | Hold |
213,000
| – | – | 0.22% | 92 |
|
|
2020
Q1 | $10.4M | Buy |
+213,000
| New | +$10.4M | 0.34% | 81 |
|
|
2018
Q3 | – | Sell |
-162,000
| Closed | -$3.3M | – | 153 |
|
|
2018
Q2 | $3.3M | Buy |
+162,000
| New | +$3.3M | 0.14% | 100 |
|